Novo Nordisk signs pact to assess semaglutide implant
Novo Nordisk, the owner of the Ozempic and Wegovy GLP-1 drugs, has announced a deal to work with a Californian…
Novo Nordisk, the owner of the Ozempic and Wegovy GLP-1 drugs, has announced a deal to work with a Californian…
The number of M&A deals in the UK food and beverage industry declined by almost a fifth in 2022, according…